Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05187312

Registry for Advanced Endoscopy

Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract

Recruiting

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical indication for endoscopic intervention/procedure

Exclusion criteria

  • No informed consent
  • Age <18 years

Treatment and study plan

Endoscopic retrograde Cholangio- pancreatography

Procedure

Endoscopic intervention in the biliary or pancreatic duct

Endoscopic Ultrasound

Procedure

Endoscopic investigation/intervention with ultrasound

Primary outcomes

  1. Adverse events

    Time frame: 30-days and 60-days post-procedure

    Incidence of Adverse events following endoscopic procedures. Measured as percentage of individuals with an adverse event

  2. Diagnostic yield

    Time frame: 1-year follow up

    Diagnostic yield after tissue sampling

Study contacts

Contact information is provided by the study sponsor or research team.

Erik von Seth, MD, PhD

CONTACT

[email protected]

+46812380000

Sponsors and collaborators

Lead sponsor

Region Stockholm

Other Gov

Collaborators

  • Karolinska Institutet

Registry information

Official study title

Research Registry for Endoscopic Treatment and Diagnostics

Acronym: ERDB

Important dates

Study start
2022
Primary completion
2032
Study completion
2032
First posted
Jan 11, 2022
Registry last updated
Apr 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.